SEC Form 4 · accession 0001437749-26-022951
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director
Period of report
Jul 7, 2026
Accepted (ET)
Jul 7, 2026 · 6:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jul 7, 2026 | A | 532,567 | $0.1135 | A | 26,408,319 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer.
- F2Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
- F3Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.